NCT02500953View on ClinicalTrials.gov

A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects
Interventions
DRUG

ASP3325

DRUG

Placebo

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY